Average Co-Inventor Count = 10.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (5 from 3,923 patents)
2. Novartis Corporation (1 from 166 patents)
3. Novartis Pharma Gmbh (8 patents)
6 patents:
1. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
2. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
3. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
4. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
5. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
6. 7253257 - Human metabotropic glutamate receptor subtype mGluR7b